Publication | Open Access
Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow‐up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients
57
Citations
27
References
2016
Year
The value of blood markers for diagnosing PNETs in MEN1 patients is relatively low, even when used in combination.
| Year | Citations | |
|---|---|---|
Page 1
Page 1